# Dakshidin Corporation (DKSC)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/DKSC/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -11.6K | N/A | N/A | N/A |
| 2025 | $ 0 | $ -42.3K | N/A | N/A | N/A |
| 2024 | N/A | N/A | N/A | $ 147.2K | $ 6.8K |
| 2023 | $ 0 | $ -19.2K | $ -6.2K | $ 147.2K | $ 6.8K |
| 2022 | $ 0 | $ -186.7K | $ 33.9K | $ 147.2K | $ 24.5K |
| 2021 | $ 2.9K | $ -257.7K | $ -416.3K | $ 124.7K | $ 191.6K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 21.66 |
| Liabilities / Eq | 60.16 |
| Current Ratio | 0.00 |

## Other views

- [Metrics](https://sponda.capital/en/DKSC.md)
- [Charts](https://sponda.capital/en/DKSC/charts.md)
- [Compare](https://sponda.capital/en/DKSC/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.